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Abstract— Hair follicles repeatedly regress and reconstitute themselves, suggesting the presence of intrinsic tissue stem cells. Among 
the unique characteristics of adult stem cells isolated from hair follicles is their ability to differentiate into keratinocytes. Study on 
chitosan skin-engineered templates (SETs) as scaffolds for the proliferation of human fibroblasts have shown the promise of SETs in 
facilitating skin cell growth in three-dimensional culture. High proliferation in three-dimensional culture using human cells allows the 
researcher to extensively evaluate the cultivation of desirable cell types on chitosan SETs. Therefore, this study aimed to evaluate the 
in vitro attachment, proliferation and differentiation of hair follicle stem cells (HFSCs) on a chitosan SETs. HFSCs were isolated from 
human scalp tissues using collagenase type I prior to propagation in supplemented CnT-07 media. The phenotype of the HFSCs was 
verified using the markers keratin-15 (K15) and CD200, as detected by immunocytochemical staining. The attachment and 
proliferation of the HFSCs on the chitosan SETs were evaluated using scanning electron microscopy (SEM), an alamar blue assay and 
a live/dead assay. Subsequently, the HFSCs were differentiated using CnT-2D differentiation media. The cells’ differentiation was 
verified using the markers involucrin and keratin-6 (K6), as detected by immunofluorescence staining. The HFSCs were successfully 
isolated, proliferated and differentiated according to staining positivity and microscopy imaging. HFSCs are able to proliferate and 
directly differentiate into keratinocytes on a chitosan SETs, which may facilitate their use in regenerative medicine. 
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I. INTRODUCTION 
The isolation of hair follicle stem cells (HFSCs) derived 
from humans has been simplified [1] and has led to a great 
opportunity for researchers to use HFSCs in differentiation 
experiments. Many studies have proven that the multipotent 
HFSCs situated in the bulge, serving as its niche [2], [3] are 
able to differentiate into sebocytes [4] and melanocytes, 
neuronal and smooth muscle cells [5] in vitro. In addition, a 
new hair follicle can be formed in reconstitution assays after 
HFSCs are combined with dermal cells [2]. Human HFSCs 
in a co-culture model were successfully demonstrated to 
regenerate tissue to replace wounded or diseased tissues both 
in acute and in chronic animal models [6]. However, studies 
of HFSC proliferation and differentiation into keratinocytes 
in vitro using scaffolds are scarce. The differentiated cells, 
and particularly keratinocytes, that are derived from human 
HFSCs are potent, especially for use in the clinical setting. 
Clinically, autograft and allograft skin grafting is still the 
gold standard for the management of burns and wounds that 
involve extensive skin loss [7]. This type of treatment leaves 
a scar and pain at the donor site. Alternative management of 
burn and wound patients is definitely challenging for plastic 
surgeons.  
The availability of a lot of cultured keratinocytes is 
certainly crucial for alternative management. Unfortunately, 
keratinocyte cultures easily undergo senescence [8], 
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impairing their application to burn and wound management. 
Another issue in the clinical setting is obtaining human 
HFSCs that have the high proliferative ability and that are 
easy to differentiate into keratinocytes [1]. Prior to grafting 
HFSCs, a delivery system is not necessary if the cells are 
cultured in a culture vessel before administration to the 
recipient because the cells must be administered in spray 
form, which is time-consuming and labor intensive. 
Differentiating cells on biocompatible and biodegradable 
scaffolds is another challenge. A scaffold must lead to 
extensive cell proliferation, and in the case of differentiation, 
the scaffold should have properties that support and trigger 
stem cell differentiation. Chitosan skin-engineered templates 
(SETs) have been proven to have potential as an applicable 
scaffold for three-dimensional culture, accelerating fibroblast 
proliferation [9]. Chitosan is a poly-(β-1, 4-D-glucosamine) 
and deacetylated derivative of chitin. Among the attractive 
features of chitosan are its biomechanical properties [10], 
which are ideally suited for skin tissue engineering [6], [9], 
[11]. The potential of chitosan in supporting HFSCs and 
their differentiation potential in three-dimensional culture is 
yet unexplored. HFSC culture on chitosan is a strategy to 
avoid technical limitations, including HFSC delivery and 
transplantation issues. The elimination of these limitations 
may render HFSCs a potential source of stem cells for 
cutaneous regenerative medicine and skin tissue engineering 
[12]. Therefore, our aim was to evaluate the attachment, 
proliferation, and differentiation of HFSCs cultured on a 
chitosan SETs for application in regenerative medicine. 
II. MATERIAL AND METHOD 
A. Preparation of Chitosan SETs 
A chitosan SETs was produced from ultrapure medical-
grade chitosan powder (Hunza Nutriceuticals Sdn Bhd., 
Nibong Tebal, Penang, Malaysia) developed at the 
Advanced Materials Research Centre of SIRIM (AMREC-
SIRIM) in Malaysia (Fig. 1). The chitosan SETs production 
procedures have been described in detail by [9], [13]. The 
chitosan powder was irradiated via gamma radiation, and the 
chitosan SETs was sterilized using ethylene oxide gas. Prior 
to use, the scaffold was quarantined for one month. The 
chitosan SETs was briefly washed with supplemented CnT-
07 media (Cell-N-Tech) prior to cell seeding. 
 
 
Raw material  Chitosan powder  Chitosan SET  
Fig. 1  AMREC-SIRIM producing Chitosan SET originated from prawn 
shell 
 
B. Morphological Analysis of Chitosan SETs 
The top surface and the cross-sectional morphology of the 
chitosan SETs were observed by scanning electron 
microscopy (SEM; Quanta 450 FEG, FEI, Netherlands) after 
specimens were coated with an ultrathin layer of gold in a 
coating apparatus. Imaging was conducted at a voltage of 20 
kV. 
C. HFSC Primary Culture and Characterization Assay 
HFSCs were obtained following a method outlined in our 
prior publications [1], [14]. All human scalp tissues used in 
this study were collected from consenting donors. The study 
was approved by the Human Ethics Committee of Universiti 
Sains Malaysia (USM) (USMKK/PPP/JEPeM [212.3(15)]). 
The cultured cells were grown in supplemented CnT-07 
media at 37°C in a 5% CO2 incubator. The HFSCs were 
characterized and their phenotype was verified following a 
method outlined in our prior publications [1], [14]. The 
HFSCs were grown in a 24-well plate until reaching 80% 
confluence before fixation in absolute methanol (Sigma) for 
15 minutes at 4°C. After that, incubation of the cells in 
normal goat serum for 20 minutes was performed. Mouse 
monoclonal anti-human keratin-15 (K15; Abcam Inc., 
1:1000 dilution) and mouse monoclonal anti-human CD200 
(Abcam Inc., 1:500 dilution) were then used as primary 
antibodies to validate the HFSCs’ phenotype. These primary 
antibodies against the markers were incubated for one hour. 
Incubation with a secondary antibody (conjugated to biotin) 
for 30 minutes was then performed, followed by a 20-minute 
incubation with streptavidin-horseradish peroxidase. 
Afterward, the cells were incubated with 3,3'-
diaminobenzidine (DAB substrate) for another 20 minutes. 
Finally, hematoxylin was added to the cells to counterstain 
the nucleus.  
D. Inclusion and Exclusion Criteria    
In normal hair cycle, the hair is actively produced because 
the hair follicle composed of hair follicle stem cells. 
Therefore, to confirm that the hair follicle stem cells are 
easily isolated, scalp samples were collected from patients 
that fulfilled these following criteria: i) Patients age less than 
60 years. This criterion was chosen because older people 
normally presented with hair loss that clearly confirmed the 
hair cycle was abnormal. ii) Scalp containing hair follicle. 
Some scalps that were collected but have no hair follicle 
have been excluded from the isolation procedures. iii) Not 
receiving radiotherapy on the head. Radiation exposure 
causes the hair loss and effects the hair follicle function. 
Meanwhile, patients having a scar on the scalp, androgenic 
alopecia and excessive open injury on the head were 
excluded from sample recruitment. 
E. HFSC Seeding on Chitosan SETs 
HFSC cultures were washed with Dulbecco’s modified 
phosphate-buffered saline (DPBS) (Gibco) and detached 
using TrypLE™ Express (Invitrogen). The cells were then 
seeded onto chitosan SETs at a seeding density of 6x106 
cells/well. The first 20 μl of cells was seeded onto the center 
of each chitosan scaffold. After three minutes, another 20 μl 
of cells was seeded onto the chitosan. This process was 
repeated until 100 μl of cells was seeded. After 30 minutes, 
100 μl of supplemented CnT-07 medium was added to 
support cell proliferation. The cultures were incubated at 
37 °C in a 5% CO2 incubator. After one hour, the chitosan-
43
  
cell constructs were transferred to 24-well plates to provide 
an adequate volume of growth media for cell proliferation. 
The chitosan-cell constructs were incubated at 37 °C and 5% 
CO2. The supplemented CnT-07 media were changed every 
day to mitigate nutrient depletion. On the third day, the 
chitosan-cell constructs were used for further experiments. 
F. HFSC Attachment on Chitosan SETs 
The chitosan-cell constructs were rinsed three times with 
DPBS for 5 minutes each and fixed with 2.5% 
glutaraldehyde (Sigma) at room temperature. The samples 
were then washed three times with PBS, dehydrated using a 
graded series of ethanol (30-100%), air dried and viewed by 
SEM. A chitosan SETs incubated with growth media alone 
was used as the negative control. 
G. Proliferation of HFSCs on Chitosan SETs Observed Via 
Laser Scanning Microscope (LSM) 
The chitosan-cell constructs were washed three times for 
5 minutes each. A LIVE/DEAD Kit (Invitrogen) was used to 
investigate HFSC proliferation on the chitosan SETs. A 200 
μl solution containing 4 mM ethidium homodimer-1 reagent 
and 2 mM calcein AM (ratio 2:1) in DPBS was used, as 
recommended by the manufacturer. Incubation of the 
chitosan-cell constructs with the solution was performed for 
45 minutes at room temperature, after which the scaffolds 
were viewed using LSM (Zeiss, Germany) with 
excitation/emission wavelengths of 495 nm/635 nm for 
ethidium homodimer-1 and of 495 nm/515 nm for calcein 
AM. A chitosan SETs incubated with growth media alone 
was used as the negative control. 
H. Viability of HFSCs on Chitosan SETs 
Chitosan-cell constructs were assessed with the alamar 
blue test (Invitrogen) for different culture periods of up to 7 
days. Alamar blue solution was also applied to the chitosan 
SETs without cells, and the data were regarded as the control. 
At different culture times, 20 µl of alamar blue solution was 
added to each well, and the samples were incubated at 37 °C 
for 4 hours. The medium (100 μl) from each well was 
transferred into a 96-well plate (Orange, Belgium) and 
analyzed using a NanoQuant enzyme-linked immunosorbent 
assay reader (Tecan, Austria). The absorbance was 
determined at 570 nm, with a reference wavelength of 600 
nm. 
I. Differentiation Ability of HFSCs 
The differentiation abilities of the HFSCs on the chitosan 
SETs and on a 6-well chamber plate were evaluated by 
immunofluorescence staining. A solution at 6x106 cells/ml 
was seeded on the chitosan scaffold, and the cells were 
differentiated using CnT02-3D induction media (Cell-N-
Tech). The differentiation of the HFSCs into epidermal 
keratinocytes was validated using a mouse anti-human 
involucrin monoclonal antibody (Abcam, UK) and a mouse 
anti-human cytokeratin-6 (K6) monoclonal antibody (Abcam, 
UK). Primary antibody incubation (1:500) was performed at 
room temperature for one hour. The involucrin- and K6-
positive cells were detected by a secondary antibody coupled 
to fluorescein isothiocyanate (FITC) (Sigma). To stain the 
nucleus, 4',6-diamidino-2-phenylindole (DAPI) (1:500) 
(Sigma) was used. All images were viewed by LSM. 
J. Statistics 
The data are presented as the mean ± standard error of the 
mean (SEM) for the live/dead assay and as the mean ± 
standard deviation (SD) for the OD values. The means of the 
groups in the live/dead assay were compared using the 
Wilcoxon signed-rank test. A significant difference was 
considered when  < 0.05. 
III. RESULTS AND DISCUSSION 
K. Microstructure of Chitosan SETs 
In the current study, the SEM images of the top surface of 
the chitosan SETs revealed a smooth, porous surface. 
Meanwhile, the cross-sectional imaging revealed 
interconnected pores. The pore size of the scaffold ranged 
from 44.41 ± 15.11 μm to 145.65 ± 18.21 μm in diameter 
(Figs. 2A and 2B). The pore size of the chitosan SETs was 
fabricated via freezing and lyophilization processes. During 
these process, ice crystals nucleate along thermal gradients, 
creating a porous structure [9], [15]. The particular porous 
structure of the chitosan SETs was fabricated with the aim of 
increasing the dimensions for cell attachment and 
proliferation. A suitable pore size for a scaffold for skin 
tissue engineering is between 100 and 200 μm [16]. Another 
report described a lyophilized collagen-chitosan scaffold 
with a pore size of 40-100 μm as containing an 
interconnected structure that increased cell proliferation and 
concurrently decreased inflammation [17]. Moreover, the 
high porosity of the scaffold increased tissue regeneration 
and supported tissue formation. Porosity on a specific scale 
accelerates specific tissue integration and vascularization. 
This can be achieved by using a high density of cells to 
proliferate throughout the scaffold and to ultimately 
regenerate the specific tissue [11]. In the area of tissue 
engineering, the function of a scaffold is actually to provide 
three-dimensional cultivation conditions and to ultimately 
enhance cell adhesion and proliferation in vitro [9], [15].  
 
  
Fig. 2  SEM images of a chitosan SET. Top surface microscopic image of 
the chitosan SET (A). Cross-sectional microscopic image of the chitosan 
SET (B). Scale bar 200 μm 
 
There is various types of the commercial produce of 
biomaterials for the proliferation of skin cells especially for 
the management of burn patients and wound infections. To 
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date, researchers from diverse pharmaceutical sector or 
research centre are still focusing on fabrication of novel 
biomaterials. The innovation of biomaterial that employs a 
new polymer or technique for skin replacement product is 
continuing.  
Currently, electrospinning is the latest technology of 
fabrication for novel biomaterial. In comparison with the 
conventional method of freeze drying that has been 
employed for fabrication of chitosan SET, electrospinning 
producing nanofibrillar scaffold. Nanofiber provides a better 
substrate for cell adhesion, proliferation and differentiation 
in 3-D culture [18]. Most importantly, the major skin cells 
particularly keratinocytes, fibroblasts and endothelial cells 
were highly grown in this type of scaffold [19]. During skin 
repair and regeneration, nanofiber leads to increased 
vascularization, re-epithelialization and enhanced 
granulation tissue formation. In future, the fabrication 
process of chitosan SET is suggested to use the 
electrospinning technique. This new technique will create 
the novel nanofiber chitosan SET and may show excellent 
results for future tissue engineering application.  
Alternatively, the culture technique of fabrication for skin 
substitute can be done via the air-liquid interface. It uses 
special commercially available of culture chamber named as 
organotypic inserts. The inserts are expensive, however, they 
lead the differentiation of skin cells into epidermis or dermis 
rapidly. They allow highly differentiated cells functions and 
structures compared with the cells cultured under immersion. 
Cells are seeded onto the permeable membrane of a cell 
culture insert. Upon reaching confluence, cells are supplied 
with culture medium to the only basal chamber and exposing 
the apical surface to air. The structure of skin substitute 
produced with this technique is almost similar to the native 
human skin [20].      
Natural polymeric scaffolds, including collagen-, 
hydrogel- or chitosan-based scaffolds, have been the focus, 
as they have favourable biomechanical properties, significant 
nutraceutical properties [21], [22] and are both 
biodegradable and biocompatible [10]. In contrast, synthetic 
materials are found to generate acidic products that cause on-
site inflammation, which is harmful to the surrounding tissue 
[23]. Furthermore, exudates and a high degree of 
inflammation may occur if a wound is surrounded by acidic 
conditions. As a natural polymeric scaffold, the chitosan 
SETs has suitable water vapor permeability (WVP). The 
function of WVP is to maintain wound bed moisture; to 
increase regeneration of the dermis; and most importantly to 
accelerate wound healing. Additionally, the chitosan SETs 
has tensile strength, which functions to increase dermal and 
epidermal regeneration [9], [24]. 
L. Primary Culture and Characterization of HFSCs 
In the current study, an overnight incubation with 
collagenase type I was performed to release hair follicles 
from the dermis of human scalps. After 48 hours of cell 
culture, groups of squamous-like cells were observed to be 
growing in supplemented CnT-07 media. After two weeks of 
culture, the grown cells had reached 70-80% confluence 
(Figs. 3A and 3B). To identify and validate the presence of 
HFSCs in the cultures, K15 and CD200 were used and 
showed positivity, indicated by brown color, in the cell 
membrane (Figs. 3C and 3D). Many studies have shown that 
K15 is highly expressed in epithelial stem cells from hair 
follicles [25]-[28]. Furthermore, in [29] show that stem cells 
expressing CD200 have high colony-forming efficiency. 
CD200 has been proven to be the best positive surface 
marker for the human hair follicle bulge. 
In this current study, the characterization of HFSCs was 
performed by examining the surface markers of CD200 and 
K15. Other negative surface markers such as CD34 and 
CD271 were not performed. Inoue and co-workers [30] 
confirmed that bulge cells possess K15-positive, CD200-
positice, CD34-negative and CD271-negative markers. 
Determination of negative surface markers is useful for 
characterizing freshly isolated human epithelial cells. 
Negative surface markers for HFSCs are recommended to 
double confirm the characterization of stem cells. 
Meanwhile, other positive markers for HFSCs are 
recommended including nestin [31] and neural crest 
characteristics [32]. The presence of stem cells with neural 
crest characteristics and nestin-positive marker in hair 
follicle is useful to confirm its pluripotency.     
To date, there is no commercially available of epithelial 
stem cells derived from the human hair follicle. The 
epithelial stem cells or epithelial cells derived from colon, 
tongue, or other organ are existed but not from the hair 
follicle. In European countries and USA, there are many 
centres of stem cells for storage or commercial purpose. As 
HFSCs are important in skin tissue engineering research, the 
plan for collaboration with the private sector for the 
establishment of HFSCs is highly suggested. 
 
 
 
Fig. 3  Primary culture of human HFSCs (A,B). Magnification 100x. 
Characterization of HFSCs using K15 (C) and CD200 (D). Magnification 
100x. Inserts represent negative control 
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M. Attachment and Proliferation of HFSCs on Chitosan 
SETs 
After 72-hour cultivation, HFSCs attached to and 
proliferated on the chitosan SETs (Fig. 4A). Live HFSCs 
predominantly covered the surface of the chitosan SETs, as 
indicated by green fluorescence (Fig. 4B). Meanwhile, red 
fluorescent dead cells were minimally found. In addition, a 
live/dead cell assay of the HFSCs on the chitosan SETs 
showed significant green fluorescence, indicating that more 
HFSCs were viable. According to the graph, at 72 hours, the 
population of living HFSCs on the chitosan SETs was 
double compared with the population of dead HFSCs (Fig. 
4C). The viability assay of the HFSCs on the chitosan SETs 
is presented in Table 1; this assay demonstrated that the 
growth of the HFSCs increased over time.  
 
 
Fig. 4  Analysis of cell-chitosan construct. SEM images of HFSCs at 72 
hours post-seeding on the chitosan SET (A). The HFSCs have attached and 
growth on the surface of the scaffold (arrows). Insert is the chitosan without 
cells. Scale bar 200 μm. Live/dead assay of HFSCs at 72 hours post-seeding 
on the chitosan (B). The viable of HFSCs expressed green fluorescent 
meanwhile the dead cells expressed red fluorescent. Insert is the control. 
Scale bar 100 µm. Graph of living and dead HFSCs on the chitosan SRT at 
72 hours post-seeding (C) (n = 3). *P ≤ 0.05 
 
This promising finding of HFSC viability and growth 
using a chitosan SETs has increased the interest of 
researchers in employing this scaffold for the fabrication of 
epidermal substitutes [6], [9], [11]. Chitosan skin substitutes 
and chitosan SETs have been demonstrated to accelerate 
wound healing in irradiated rats. Both of these materials 
have also been found to significantly decrease the size of the 
scar [6]. In addition to the above finding, the current study 
suggests that the chitosan SETs supports the initial 
attachment, spreading and proliferation of HFSCs in vitro. 
This phenomenon is likely due to close binding between the 
positively charged chitosan and the negatively charged cells 
[21]. Other reports have demonstrated that both fibroblasts 
and keratinocytes attached to and proliferated well on a 
chitosan-based scaffold [33], [34]. A previous study [35] has 
successfully created chitosan-based scaffolds that were used 
to construct an artificial skin bilayer in vitro using a co-
culture technique, and other studies demonstrated that the 
peripheral nerve could also be regenerated [6], [25], [36]. All 
of the reports have shown that chitosan-based material is a 
promising scaffold for the attachment and proliferation of 
mostly skin cells, which support skin regeneration. 
Another suggestion to increase the attachment of HFSCs 
onto chitosan is via co-culture with fibroblasts. The dynamic 
of co-culture between fibroblast and epithelial cells in skin 
tissue engineering has clearly shown that the interaction of 
these two cells regulate skin homeostasis, control the growth, 
migration, and differentiation of epithelial cells, and 
establish autoimmune activities. Co-culture between HFSCs 
and HDFs in the previous study has shown an interaction by 
which a skin-like structure was produced after HFSCs were 
overlaid on HDFs. The HFSCs were overlaid on the 
fibroblasts after the fibroblasts were seeded in chitosan for 
two weeks and the co-culture was done for a further one 
week. The high density of cells (3x106/cm2) was chosen as it 
promotes cell attachment, infiltration, and uniform 
distribution throughout the construct [37]. Co-culture 
between HDFs and HFSCs may secret various soluble 
cytokines, growth factors and extracellular matrix 
components which promote proliferation of epithelial cells.  
TABLE I 
OD570 VALUE OF HFSCS VIABILITY CULTURED ON THE CHITOSAN SET 
(MEAN ± SD, N = 6) 
 
N. Differentiation of HFSCs on Chitosan SETs 
The investigation of HFSC differentiation into 
keratinocytes on chitosan SETs was performed. The cells on 
the chitosan SETs were differentiated into epidermal 
keratinocytes, as indicated by the green fluorescence staining 
of the markers K6 and involucrin (Figs. 5A and 5B). Stem 
cells have the ability to differentiate, providing an ideal 
source for skin replacement products. Stem cells can 
differentiate into specialized cell types in vitro, as 
demonstrated by HFSCs, adipose stem cells and bone 
marrow-derived human mesenchymal stem cells [1], [38], 
[39]. Previous studies have reported that stem cells 
proliferated on chitosan-based scaffolds and successfully 
differentiated into nucleus pulposus (NP)-like cells and 
osteoblasts [40], [41]. A report by [42] showed that HFSCs 
adhered, proliferated, and differentiated on a poly-L-lactic 
acid nanofiber scaffold for peripheral nerve regeneration. 
Our study aimed to obtain baseline knowledge of the 
differentiation of HFSCs into keratinocytes, which, in the 
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future, could be used for skin grafting. The differentiation of 
HFSCs into epidermal keratinocytes is an alternative way to 
achieve skin regeneration in a burn patient. Classically, 
epidermal keratinocytes were isolated from a skin sample 
and propagated on murine fibroblasts that were first 
irradiated, known as a feeder layer. The feeder layer 
supported expansion and proliferation of the cells. The 
culture duration for the keratinocytes was prolonged until a 
thick layer that contained two or three sublayers were 
fabricated, known as a cultured epithelial autograft (CEA) 
[43]. CEAs are used in the treatment of burn patients and are 
combined with nylon or polyglactin mesh [44]. In the current 
study, the use of a feeder layer to grow HFSCs was omitted, 
providing a simplified technique for differentiated 
keratinocyte formation. Therefore, HFSCs were cultured on 
a chitosan SETs as an alternative to feeder layer adaptation.   
 
 
Fig. 5  Differentiation of HFSCs into keratinocytes on the chitosan SET at 
72 hours post-seeding. The HFSCs expressed green fluorescent for 
involucrin (A) and K6 (B). Nucleus stained blue. Chitosan stained light 
blue. Scale bar 200 µm 
 
Although HFSCs can be grown and differentiated on 
chitosan SETs, in our opinion, more studies are needed to 
facilitate the proliferation of cells on chitosan SETs. One 
effective approach is to use a bioreactor, which enables the 
circulation of nutrients and eliminates waste during the 
development and proliferation of HFSCs on scaffolds and 
which enhances the rate of growth. A bioreactor provides 
complete monitoring of and control over intrinsic factors 
[45]. In addition, a bioreactor allows the investigator to 
determine the roles of specific biological, chemical and 
physical parameters. TransCyte and Dermagraft are among 
the products that have been produced using a perfusion 
bioreactor [46].  
Apart of chitosan that supporting the cultivation of stem 
cells and cells of connective tissue, there are a few scaffolds 
that support the cultivation of human cells. Collagen, for 
instance, is the most abundantly used for human skin cells’ 
growth and differentiation. Collagen is easily found in 
bovine, porcine or fish and as the main resource in tissue 
component of tendon, dermis, bone and other parts of the 
bodies. Biocompatibility and biodegradability of collagen 
increase its application for skin grafting in varies form such 
as film, paste, gel, and sponge. However, collagen from the 
mammalian source causes prion disease transmission to 
human. Another crucial scaffold that mainly used in surgery 
is fibrin. Fibrin is isolated in human blood and increases the 
renewal of damage tissue. After mesenchymal stem cells 
derived from bone marrow are seeded into fibrin, the tissue 
regeneration has successfully engineered with less scar 
formation. The limited source of row human blood affects it 
uses in a the clinical setting. Commercial fibrin kit is 
available however, patients with severe disease are not 
affordable to pay due to its high cost. Therefore, chitosan is 
an alternative scaffold for tissue regeneration based on its 
low cost, do not introduce transmission to human and highly 
foster healing process.         
IV. CONCLUSION 
Our study showed that HFSCs were successfully isolated 
and further proliferated in three-dimensional cultivation. 
Human anti-K15 and anti-CD200 antibodies were used for 
verification of isolated cultures, and a live/dead assay was 
used to confirm the viability of the HFSCs during cultivation 
on chitosan SETs. Subsequently, we tested the ability of the 
HFSCs to differentiate into epidermal keratinocytes after 
culture in epidermal induction medium. In addition, the 
current study showed that a chitosan SETs supports the 
attachment, proliferation, and differentiation of HFSCs, 
which is promising for application in skin tissue engineering. 
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